< Back to scientific publications

Magazine

Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.

Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).

Date: 2012

Scope of interest: Hematology/Transfusion Medicine




You may also be interested in:

Report/Poster of Convention/Congress Act

Rubik’s Cube Reflected Crisis

Authors: M. Albini, M. Fanella, J. Fattouch, S. Casciato, A. Morano, L.M. Basili, A.T. Giallonardo, C. Di Bonaventura

Date: 2016

Scope of interest: Epilepsy


Read details
Magazine 11.50

Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations.

Authors: Lapenta L, Morano A, Casciato S, Fanella M, Fattouch J, Vaudano AE, Gregori B, Vanacore N, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2014

Scope of interest: Epilepsy


Read details
Magazine 7.15

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian? oRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2022

Scope of interest: Epilepsy


Read details